Adenosine in trauma and sepsis
Adenosine in trauma and sepsis
批准号:
7429510
负责人:
George HASKO
金额:
$27.21万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2008-04-30
关键词:
AdenosineAdenosine A3 ReceptorAnimalsApoptosisAzathioprineBindingCell Surface ReceptorsCellsCessation of lifeComplexDiseaseEnzymesFunctional disorderFundingGenerationsGeneticGenetic TranscriptionGram-Positive BacteriaGrowthImmuneImmune responseImmunityImmunosuppressionImmunosuppressive AgentsInfectionInflammationInflammatoryInjuryInvestigationIschemiaKnowledgeLaboratoriesLeadLigationMediatingMediator of activation proteinMetabolic PathwayMetabolic stressMusOrganPathway interactionsPhysiologicalProductionPuncture procedurePurine NucleosidesPurinergic P1 ReceptorsRegulatory PathwayRelative (related person)ReportingRoleSepsisSignal PathwaySignaling MoleculeSiteStimulusStressSystemTestingTherapeutic immunosuppressionTraumaWorkbasecytokineextracellularimmunoregulationinsightmacrophagemortalitynovelpreventreceptorreceptor expressionseptic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purine nucleoside adenosine is a biologically active extracellular signaling molecule that is formed at
sites of metabolic stress associated trauma and sepsis. Adenosine can bind to one or more of four cell
surface receptors (A1, A2A, A2B, and A3) through which it exerts varying immunomodulatory effects. During
the previous funding period, we tested the hypothesis that high concentrations of endogenous adenosine
contribute to immunosuppression, promote bacterial growth, and worsen mortality in animals with
intraabdominal polymicrobial sepsis. Because A2A receptors are generally immunosuppressive, we focused
our investigations on the role of these receptors in mediating the immunosuppressive effects of adenosine in
sepsis. We have discovered that stimulation of A2A receptors with endogenous adenosine contributes to the
mortality of mice subjected to a septic insult. This decreased survival of mice caused by A2A receptor
stimulation was tightly associated with a capacity of A2A receptor stimulation to increase bacterial burden, to
augment immune cell apoptosis, and to increase production of inflammatory cytokines. Although our studies
testing the role of A2A receptors validate the hypothesis that adenosine has potentially lethal
immunosuppressive and infection-promoting effects following sepsis, further work performed during the
previous cycle suggests that adenosine has a more complex role in the pathophysiology of sepsis. Thus to
better understand the complex regulatory pathways of the adenosine receptor system in sepsis, we propose
the following highly integrated Specific Aims: Aim 1: Elucidate the effect of global adenosine deficiency in
regulating immune responsiveness during sepsis. Aim 2: Elucidate the role and the relative importance of
A1, A2B and A3 adenosine receptors in regulating immunity during sepsis. New knowledge about the control
of septic immunity by distinct adenosine receptors could lead to the identification of novel pharmacological
approaches for ameliorating the course of disease and preventing death in sepsis. Aim 3: Elucidate the
receptors and intracellular signaling pathways that mediate the modulatory effects of adenosine on the
transcription and secretion of cytokines by macrophages stimulated with Gram-negative and Gram-positive
bacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Recombinant E-NTPDase for shock
-
批准号:10757117
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2023
-
负责人:George HASKO
-
依托单位:
A2B receptor stimulation for sepsis
-
批准号:10545455
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2022
-
负责人:George HASKO
-
依托单位:
Neutrophil A2A receptors in sepsis
-
批准号:10478933
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2021
-
负责人:George HASKO
-
依托单位:
Neutrophil A2A receptors in sepsis
-
批准号:10267891
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2021
-
负责人:George HASKO
-
依托单位:
Neutrophil A2A receptors in sepsis
-
批准号:10657737
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2021
-
负责人:George HASKO
-
依托单位:
Soluble E-NTPDase for sepsis
-
批准号:9253962
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2017
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6910677
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6637820
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:7655450
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8069950
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6757946
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6533462
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8504024
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8733173
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8900797
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:9113958
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Purinergic signaling in trauma and sepsis
-
批准号:9379950
-
项目类别:
-
资助金额:$13.62万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:7370902
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
TREATMENT OF ARTHRITIS WITH AN ADENOSINE-3 AGONIST
-
批准号:2870252
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:George HASKO
-
依托单位:
NOVEL PARS INHIBITOR FOR THE THERAPY OF COLITIS
-
批准号:2825975
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:George HASKO
-
依托单位:
海外基金